POST Online Media Lite Edition


Genmab: CEO Lisa N. Drakeman retires

Staff writer |
Copenhagen, Denmark - June 15, 2010, Copenhagen, Denmark - Genmab A/S, a biotechnology company, announced that its co-founder Lisa N. Drakeman retires from her position as CEO and director.

Article continues below

Dr. Drakeman has served as Genmab’s President and CEO since inception and is also a member of the board of directors. Dr. Drakeman has over 18 years of experience working in the biotechnology industry, including establishing corporate partnerships with major pharmaceutical companies, managing clinical trials and developing government programs for financing biotechnology research.

Dr. Drakeman previously served as a member of the faculty and administration at Princeton University and as Senior Vice President, Head of Business Development for Medarex, Inc. Dr. Drakeman serves on the board of BioNJ.


BioMar announces new global director of R&D
Zealand Pharma appoints Frank Sanders as U.S. president
BioMar appoints managing director in Australia
BioMar announces new top management in the salmon division
BioMar icon Niels Alsted retires after 45 years in aquaculture

What to read next

Genmab adds three new directors
Lisa Montague appointed chief executive officer of Loewe
Northrop Grumman elects Lisa Davis as corporate VP, communications